cinacalcet has been researched along with Adverse Drug Event in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ding, D; Fang, H; Kelly, R; Liu, Z; Shi, Q; Tong, W | 1 |
| Burnier, M; Forni Ogna, V; Pruijm, M; Tousset, E; Wuerzner, G; Zweiacker, C | 1 |
| Hussar, DA | 1 |
1 review(s) available for cinacalcet and Adverse Drug Event
| Article | Year |
|---|---|
New drugs 05, part I.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antidotes; Antineoplastic Agents; Bevacizumab; Cinacalcet; Drug Therapy; Drug-Related Side Effects and Adverse Reactions; Ferrocyanides; Humans; Hyperparathyroidism; Naphthalenes; Pharmaceutical Preparations | 2005 |
1 trial(s) available for cinacalcet and Adverse Drug Event
| Article | Year |
|---|---|
Clinical benefits of an adherence monitoring program in the management of secondary hyperparathyroidism with cinacalcet: results of a prospective randomized controlled study.
Topics: Calcimimetic Agents; Causality; Cinacalcet; Comorbidity; Drug Monitoring; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Medication Adherence; Middle Aged; Naphthalenes; Prevalence; Risk Factors; Switzerland; Treatment Outcome | 2013 |
1 other study(ies) available for cinacalcet and Adverse Drug Event
| Article | Year |
|---|---|
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
Topics: Animals; Anti-Infective Agents; Anti-Inflammatory Agents; Chemical and Drug Induced Liver Injury; Databases, Factual; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Models, Biological; Predictive Value of Tests | 2011 |